Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study

BACKGROUND: For treatment of relapsing-remitting multiple sclerosis (RRMS), a broad range of disease-modifying therapies (DMT) is available. However, few comparative effectiveness studies between different drugs have been performed. OBJECTIVES: This study aimed to compare the efficacy and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Pape, Katrin, Rolfes, Leoni, Steffen, Falk, Muthuraman, Muthuraman, Korsen, Melanie, Meuth, Sven G., Zipp, Frauke, Bittner, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772974/
https://www.ncbi.nlm.nih.gov/pubmed/36568489
http://dx.doi.org/10.1177/17562864221142924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772974/
https://www.ncbi.nlm.nih.gov/pubmed/36568489
http://dx.doi.org/10.1177/17562864221142924

Ejemplares similares